Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, February, 2009 - PR & Med Ed

New pharmaceutical account wins notified to us by the winning agency for the period December 2008 to January 2009 inclusive

New pharmaceutical account wins notified to us by the winning agency for the period December 2008 to January 2009 inclusive:

 

CLIENT

PRODUCT

THERAPEUTIC AREA

WINNING AGENCY

AstraZeneca RECENTIN Recurrent glioblastoma multiforme and colorectal cancer IMC Medical Communication
AstraZeneca ZD4054 Prostate cancer IMC Medical Communication
Baxter Europe Advate and FEIBA Haemophilia Ashley Communications
Roche Pegasys Hepatitis C and B Ketchum
Sanofi-aventis/ Bristol-Myers Squibb n/a Cardiovascular Medaxial
SPD Development Company Clearblue digital pregnancy test with conception indicator Women's health IMC Medical Communication
Typharm Dermatology portfolio Dermatology echo
TOPRA Corporate n/a Ash Healthcare
 Wyeth  ReFacto Haemophilia ROAD 

  

Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

5th March 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics